- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Tech giants, Big Pharma and insurers are all angling to profit from the $3 trillion-plus U.S. healthcare market.
The Danish pharmaceuticals maker is facing tighter margins and tougher competition in the U.S.
Gainers include ArcelorMittal, Lafargeholcim, Nokia, Maersk
UnitedHealth becomes the second major healthcare provider to scratch the insulin product from its 2017 medicines roster.